Radu Mircea Neagoe1, Mircea Mureșan2, Șerban Bancu1, Ionuț Balmos1, Vasile Băișan1, Septimiu Voidăzan3, Daniela Sala1. 1. Surgery Clinic No. 2, University of Medicine and Pharmacy of Târgu Mureș, Gh. Marinescu St., No. 50, 540109, Tîrgu Mureș, Romania. 2. Surgery Clinic No. 2, University of Medicine and Pharmacy of Târgu Mureș, Gh. Marinescu St., No. 50, 540109, Tîrgu Mureș, Romania. dr_muremir@yahoo.com. 3. Epidemiology Department, University of Medicine and Pharmacy of Târgu Mureș, Tîrgu Mureș, Romania.
Abstract
INTRODUCTION: Laparoscopic sleeve gastrectomy (LSG) has gained ground in Eastern Europe in the decade but fewer reports of large series with medium-term follow-up exist. We describe a single-surgeon experience in LSG (the first 101 consecutive cases) in a Balkan emerging bariatric center. METHODS: A prospectively maintained database of the initial 101 consecutive patients submitted to LSG in our clinic between October 2010 and February 2016 was reviewed. RESULTS: The percentages of mean excess weight loss (%EWL) in the 101 patients (mean age of 42 ± 10.6 years, 77 % female, median preoperative body mass index (BMI) of 44.5 kg/m2) were 51.3 (n = 82 followed-up patients) at 6 months postoperatively, 78.2 (n = 69) at 1 year, and 75.8 (n = 39), 77.1 (n = 20), 67.5 (n = 17), and 52.9 (n = 7) at 2, 3, 4, and 5 years, respectively. One year after LSG, all comorbidities showed remission or significant improvement in all 69 followed-up patients; the highest resolution was seen with hypertension (73.3 %). We noted a negative correlation between a decrease in %EWL and both the age of the patient and the initial state weight and BMI. The mortality in our group was nil; we had three cases (2.9 %) of bleeding and no leaks. CONCLUSIONS: LSG is a safe procedure, with low postoperative morbidity rates and excellent short-term %EWL results up to 3 years after surgery, including resolution or improvement of the main obesity-related comorbidities. The results were superior in the category of younger and lower initial BMI obese patients.
INTRODUCTION: Laparoscopic sleeve gastrectomy (LSG) has gained ground in Eastern Europe in the decade but fewer reports of large series with medium-term follow-up exist. We describe a single-surgeon experience in LSG (the first 101 consecutive cases) in a Balkan emerging bariatric center. METHODS: A prospectively maintained database of the initial 101 consecutive patients submitted to LSG in our clinic between October 2010 and February 2016 was reviewed. RESULTS: The percentages of mean excess weight loss (%EWL) in the 101 patients (mean age of 42 ± 10.6 years, 77 % female, median preoperative body mass index (BMI) of 44.5 kg/m2) were 51.3 (n = 82 followed-up patients) at 6 months postoperatively, 78.2 (n = 69) at 1 year, and 75.8 (n = 39), 77.1 (n = 20), 67.5 (n = 17), and 52.9 (n = 7) at 2, 3, 4, and 5 years, respectively. One year after LSG, all comorbidities showed remission or significant improvement in all 69 followed-up patients; the highest resolution was seen with hypertension (73.3 %). We noted a negative correlation between a decrease in %EWL and both the age of the patient and the initial state weight and BMI. The mortality in our group was nil; we had three cases (2.9 %) of bleeding and no leaks. CONCLUSIONS: LSG is a safe procedure, with low postoperative morbidity rates and excellent short-term %EWL results up to 3 years after surgery, including resolution or improvement of the main obesity-related comorbidities. The results were superior in the category of younger and lower initial BMI obesepatients.
Authors: Timothy M Farrell; Stephen P Haggerty; D Wayne Overby; Geoffrey P Kohn; William S Richardson; Robert D Fanelli Journal: Surg Endosc Date: 2009-01-06 Impact factor: 4.584
Authors: Radu Neagoe; Mircea Muresan; Daniel Timofte; Ruxandra Darie; Ion Razvan; Septimiu Voidazan; Simona Muresan; Daniela Sala Journal: Wideochir Inne Tech Maloinwazyjne Date: 2019-04-08 Impact factor: 1.195